BlackRock vs. Goldman Sachs: Which Is the Better Investment After Record Q2 Results?

BlackRock’s Q2 results were record-setting: AUM surpassed $15T for the first time (+$192B net inflows), revenue rose 30% YoY to $7.08B vs $6.82B estimates, and adjusted EPS reached $13.91 (up 15%) nearly 10% above $12.67. Goldman delivered a more explosive quarter with Q2 revenue up 39% YoY to $20.33B (23% above $16.49B) and adjusted EPS of $20.98 (45% above $14.47), driven by +53% Global Banking & Markets revenue and +55% higher investment banking fees. Both firms signaled continued optimism for the second half, with BlackRock boosting buybacks to $550M/quarter and ~$2B full-year while Goldman’s higher growth profile supports the argument for cyclical upside.

Analysis

The key market takeaway is that these are not the same stock even though both are winning. GS is the more cyclical earnings lever: the operating set-up is favorable now, but that mix of underwriting, trading, and advisory is exactly where estimates can peak fast if capital markets volume normalizes. BLK is the higher-quality compounding story because fee streams, buybacks, and operating leverage make the earnings base less fragile; the market is paying for durability, not just a hot quarter.

Second-order, this likely supports the broader financial complex, but the spillover is uneven. NDAQ benefits if issuance and secondary activity stay elevated, while brokers and capital-markets-dependent peers get more operating leverage than banks with lending-heavy books. The more important question over the next 1-3 months is whether GS’s revenue mix proves sustainable; if not, the stock can underperform even with good absolute numbers because its multiple is already less forgiving versus history.

Contrarian view: consensus may be underestimating how much of BLK’s AUM strength is beta-driven rather than purely sticky flow, which matters if equities wobble. Conversely, GS’s beat may be over-discounted as ‘too cyclical to trust,’ but if deal pipelines and underwriting stay hot into the next quarter, the market could keep re-rating the stock despite its above-normal historical multiple. For 6-18 months, BLK looks like the cleaner compounder; GS needs the cycle to stay open to justify continued upside.

Key Decisions for Investors

• Long BLK / short GS as a 1-3 month relative-value pair: favor the recurring-fee and buyback profile over a capital-markets earnings stream that can mean-revert quickly; target 5-8% pair alpha, with the thesis broken if GS keeps posting >20% ROE and >40% y/y banking growth next quarter.
• Own BLK on pullbacks rather than chasing strength: the cleaner risk/reward is to buy weakness on any post-earnings digestion, since the downside is cushioned by fee visibility and capital return; thesis weakens if quarterly inflows slip materially below current run-rate or operating margin falls back under the mid-40s.
• Use GS as a tactical momentum trade only, not a core hold: initiate or add only if capital markets activity stays elevated into the next earnings season; otherwise, expect multiple compression as the market starts pricing peak-cycle earnings.
• Watch NDAQ as the quieter beneficiary of the same issuance cycle: if equity/debt underwriting stays active for another quarter, NDAQ should get a steady but lower-beta lift; if issuance rolls over, it is the cleaner short-duration expression versus GS.
• Falsifier alert: if the next macro and deal-flow prints confirm another strong quarter of underwriting and trading, the bearish relative-value case on GS is wrong and the better move is to rotate from BLK relative outperformance into outright financials exposure.